# Vistagen Therapeutics, Inc.: Exit or restructuring costs (Form 8-K, 2026-10-30)

**Trigger Strength Score:** 35/100

| Field | Value |
|---|---|
| Company | Vistagen Therapeutics, Inc. |
| Ticker | VTGN |
| CIK | 1411685 |
| Filed | 2026-10-30 |
| Event date | 2026-10-26 |
| Primary trigger | Exit or restructuring costs |
| All items | 2.05 Exit or restructuring costs; 8.01 Other events |
| Location | South San Francisco, CA |
| SIC code | 2834 |
| Accession | 0001628280-26-068627 |

## Why this score
- Primary trigger: Exit or restructuring costs.

Source: SEC EDGAR Form 8-K current reports (https://www.sec.gov/Archives/edgar/data/1411685/000162828026068627/vtgn-20261026.htm). Last refreshed: 2026-11-04T21:30:57.707Z.
Event classification uses the item numbers companies report on Form 8-K; read the filing itself before acting. Informational only; not investment advice and not an offer or solicitation to buy or sell any security.